Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

4,542 results
MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 24
1992 38
1993 67
1994 73
1995 76
1996 89
1997 89
1998 90
1999 92
2000 103
2001 119
2002 122
2003 126
2004 159
2005 157
2006 190
2007 180
2008 203
2009 262
2010 239
2011 245
2012 315
2013 287
2014 310
2015 357
2016 347
2017 304
2018 254
2019 106
Text availability
Article attribute
Article type
Publication date

Search Results

4,542 results
Results by year
Filters applied: . Clear all
Page 1
Endometrial cancer.
Morice P, et al. Lancet 2016 - Review. PMID 26354523
Endometrial cancer is the most common gynaecological tumour in developed countries, and its incidence is increasing. The most frequently occurring histological subtype is endometrioid adenocarcinoma. ...Trials are ongoing in patients at high risk of recurrence (including chemotherapy, chemoradiation therapy, and molecular targeted therapies) to assess the modalities that best balance optimisation of survival with the lowest adverse effects on quality of life....
Endometrial cancer is the most common gynaecological tumour in developed countries, and its incidence is increasing. The most frequently occurring histological subtype is endometrioid adenocarcinoma. ...Trials are ongoing in patients at high risk of recurrence (including chemotherapy, chemora
Treatment strategies for endometrial cancer: current practice and perspective.
Lee YC, et al. Curr Opin Obstet Gynecol 2017 - Review. PMID 27941361
Despite encouraging results in drug development for treatment of advanced/recurrent endometrial cancer, no targeted therapies beyond hormonal therapy are approved. There is an urgent need for scientifically validated therapy with predictive biomarkers. SUMMARY: Our understanding of endometrial cancer has evolved through improvements in molecular biology, allowing improved definition of target-specific therapies. ...
Despite encouraging results in drug development for treatment of advanced/recurrent endometrial cancer, no targeted therapies beyond hormonal therapy are approved. There is an urgent need for scientifically validated therapy with predictive biomarkers. SUMMARY: Our understanding …
Systemic therapy for endometrial stromal sarcomas: current treatment options.
Serkies K, et al. Ginekol Pol 2016 - Review. PMID 27629136 Free article.
Uterine endometrial stromal sarcomas including true low-grade endometrial stromal sarcoma (LG-ESS) and high-grade (HG-ESS) or undifferentiated endometrial sarcoma (UES) constitute a group of rare, aggressive malignancies. ...Surgery is the principal primary therapy for endometrial stromal sarcomas and should be considered in all cases. These malignancies are relatively radio- and chemoresistant. ...
Uterine endometrial stromal sarcomas including true low-grade endometrial stromal sarcoma (LG-ESS) and high-grade (HG-ESS) or undifferentiated endometrial sarcoma (UES) constitute a group of rare, aggressive malignancies. ...Surgery is the principal primary therapy for …
Endometrial cancer.
Sorosky JI. Obstet Gynecol 2012 - Review. PMID 22825101
Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in more than 40% of cases. ...Minimally invasive surgical techniques have become established as standard therapy for treating women with endometrial cancer. ...
Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in more than 40% of cases. ...Minimally invasive surgical techniques have become established as standard therapy for treating women with endometrial cancer. ...
Low-Grade Endometrial Stromal Sarcoma - a Review.
Thiel FC and Halmen S. Oncol Res Treat 2018 - Review. PMID 30317238 Free article.
In addition, the classification of endometrial stromal tumors presented difficulties for quite some time so that in earlier studies it was not always possible to precisely distinguish between LG-ESS, high-grade endometrial stromal sarcoma, and undifferentiated uterine sarcoma. ...Endocrine therapy with gestagens and aromatase inhibitors is under discussion to provide adjuvant treatment for patients with advanced stages of the disease. ...
In addition, the classification of endometrial stromal tumors presented difficulties for quite some time so that in earlier studies it was not always possible to precisely distinguish between LG-ESS, high-grade endometrial stromal sarcoma, and undifferentiated uterine sarcoma. ...Endoc …
Prevention Strategies in Endometrial Carcinoma.
MacKintosh ML and Crosbie EJ. Curr Oncol Rep 2018 - Review. PMID 30426278 Free PMC article.
PURPOSE OF THE REVIEW: To assess the most recent high-quality evidence for endometrial cancer prevention strategies. RECENT FINDINGS: Obesity is an established risk factor for endometrial cancer. Weight cycling and weight gain in middle age are risk factors for endometrial cancer. Bariatric surgery reduces the risk of endometrial cancer by up to 81% in obese women who attain and maintain a normal weight. ...
PURPOSE OF THE REVIEW: To assess the most recent high-quality evidence for endometrial cancer prevention strategies. RECENT FINDINGS: Obesity is an established risk factor for endometrial cancer. Weight cycling and weight gain in middle age are risk factors for endometrial cance …
Chemotherapy for Endometrial Cancer in Adjuvant and Advanced Disease Settings.
Bestvina CM and Fleming GF. Oncologist 2016 - Review. PMID 27412393 Free PMC article.
: Level I evidence exists for use of adjuvant chemotherapy in stage IIIC endometrial cancer (positive lymph nodes), although results of randomized trials have varied. ...One of the largest of these trials, Postoperative Radiation Therapy in Endometrial Carcinoma 3 (PORTEC-3), has completed accrual and is awaiting data maturation. ...
: Level I evidence exists for use of adjuvant chemotherapy in stage IIIC endometrial cancer (positive lymph nodes), although results of randomized trials have varied. ...One of the largest of these trials, Postoperative Radiation Therapy in Endometrial Carcinoma 3 (PORTEC-3), ha …
Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions.
De Boer SM, et al. Expert Rev Anticancer Ther 2019 - Review. PMID 30295094
Although the majority of women with endometrial cancer have a favorable prognosis due to early symptoms, 15-20% have high-risk disease features and are at increased risk of recurrence. ...Areas covered: This review focuses on the current evidence on adjuvant treatment for women with high-risk endometrial cancer and future perspectives. ...
Although the majority of women with endometrial cancer have a favorable prognosis due to early symptoms, 15-20% have high-risk disease features and are at increased risk of recurrence. ...Areas covered: This review focuses on the current evidence on adjuvant treatment for women with high-risk …
[Overview of Endometrial Cancer].
Li CC and Feng TH. Hu Li Za Zhi 2016. PMID 27699734 Chinese.
Endometrial cancer is the most common gynecological cancer and the sixth most common cancer among women in Taiwan. Risk factors for endometrial cancer include obesity, long-term estrogen replacement therapy, diabetes mellitus, hypertension, nulliparty, early age at menarche, late age at menopause, and tamoxifen therapy. Most women with endometrial cancer exhibit abnormal uterine bleeding. Endometrial cancer is often diagnosed at stage I. Surgery alone is the primary treatment for stage I endometrial cancer. ...
Endometrial cancer is the most common gynecological cancer and the sixth most common cancer among women in Taiwan. Risk factors for endometrial cancer include obesity, long-term estrogen replacement therapy, diabetes mellitus, hypertension, nulliparty, early age at menarche, lat
[European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer].
Ballester M, et al. Bull Cancer 2017. PMID 29173977 French.
Endometrial cancer (EC) is a major source of morbidity and mortality in women worldwide. In France, in 2015, EC was the first gynecological cancer in terms of incidence. ...
Endometrial cancer (EC) is a major source of morbidity and mortality in women worldwide. In France, in 2015, EC was the first gynecological cancer in terms of incidence. ...
4,542 results
Jump to page
Feedback